Genomic alterations and the pathogenesis of glioblastoma

Cell Cycle

Volumn 10, Issue 8, 2011, Pages 1174-1175

  Duncan, Christopher G ^a   Yan, Hai ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1p36; 4p16; Copy number; ERRFI1; Genomics; Glioblastoma; Mutation; Signaling pathway; TACC3

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOCITRATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR A; PROTEIN P53; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN; SCATTER FACTOR RECEPTOR;

CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME SEGREGATION; COPY NUMBER VARIATION; EDITORIAL; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOMICS; GLIOBLASTOMA; HUMAN; MITOSIS; PATHOGENESIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 79954460422     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.8.15225     Document Type: Editorial

References (11)

1. Cancer Genome Atlas Research Network. Nature 2008; 455:1061-8.
2. Parsons DW, et al. Science 2008; 321:1807-12.
3. Ohgaki H, et al. Cancer Sci 2009; 100:2235-41.
4. Purow B, et al. Nat Rev Neurol 2009; 5:419-26.
5. Yan H, et al. N Engl J Med 2009; 360:765-73.
6. Dang L, et al. Nature 2009; 462:739-44.
7. Reitman ZJ, et al. Proc Natl Acad Sci USA 2011; 108:3270-5.
8. Verhaak RG, et al. Cancer Cell 2010; 17:98-110.
9. Duncan CG, et al. Oncotarget 2010; 1:265-77.
10. Marumoto T, et al. Nat Rev Cancer 2005; 5:42-50.
11. Cloughesy TF, et al. Clin Cancer Res 2011; 17:6-11.